Byssochlamys spectabilis (Udagawa et Suzuki) Houbraken et Samson
商品貨號
B211910
Deposited As
Paecilomyces variotii Bainier
Strain Designations
MF5537
Application
produces sphingofungin E
produces sphingofungin F
Biosafety Level
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
freeze-dried
Storage Conditions
Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section
Type Strain
no
Disclosure
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC.
Preceptrol®
no
Medium
ATCC® Medium 323: Malt agar medium
ATCC® Medium 336: Potato dextrose agar (PDA)
ATCC® Medium 343: V8 juice agar
Dung of cottontail rabbit, Sylvilagus floridanus, Santa Catalina Mountains, AZ
References
Horn WS, et al. Sphingofungins E and F: novel serinepalmitoyl transferase inhibitors from Paecilomyces variotii. J. Antibiot. 45: 1692-1696, 1992. PubMed: 1474000
Kurtz MB, et al. Antibiotic eicosenoic acids. US Patent 5,233,062 dated Aug 3 1993
